Cargando…
Cell membrane fluidity and ROS resistance define DMSO tolerance of cryopreserved synovial MSCs and HUVECs
OBJECTIVES: Synovial mesenchymal stem cells (MSCs) have high freeze–thaw tolerance, whereas human umbilical vein endothelial cells (HUVECs) have low freezing tolerance. The differences in cell type-specific freeze–thaw tolerance and the mechanisms involved are unclear. This study thus aimed to ident...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9066911/ https://www.ncbi.nlm.nih.gov/pubmed/35505370 http://dx.doi.org/10.1186/s13287-022-02850-y |
_version_ | 1784699895377035264 |
---|---|
author | Mizuno, Mitsuru Matsuzaki, Takahisa Ozeki, Nobutake Katano, Hisako Koga, Hideyuki Takebe, Takanori Yoshikawa, Hiroshi Y. Sekiya, Ichiro |
author_facet | Mizuno, Mitsuru Matsuzaki, Takahisa Ozeki, Nobutake Katano, Hisako Koga, Hideyuki Takebe, Takanori Yoshikawa, Hiroshi Y. Sekiya, Ichiro |
author_sort | Mizuno, Mitsuru |
collection | PubMed |
description | OBJECTIVES: Synovial mesenchymal stem cells (MSCs) have high freeze–thaw tolerance, whereas human umbilical vein endothelial cells (HUVECs) have low freezing tolerance. The differences in cell type-specific freeze–thaw tolerance and the mechanisms involved are unclear. This study thus aimed to identify the biological and physical factors involved in the differences in freeze–thaw tolerance between MSCs and HUVECs. MATERIALS AND METHODS: For biological analysis, MSC and HUVEC viability after freeze-thawing and alteration of gene expression in response to dimethyl sulfoxide (DMSO, a cryoprotectant) were quantitatively evaluated. For physical analysis, the cell membrane fluidity of MSCs and HUVECs before and after DMSO addition was assessed using a histogram for generalized polarization frequency. RESULTS: HUVECs showed lower live cell rates and higher gene expression alteration related to extracellular vesicles in response to DMSO than MSCs. Fluidity measurements revealed that the HUVEC membrane was highly fluidic and sensitive to DMSO compared to that of MSCs. Addition of CAY10566, an inhibitor of stearoyl-coA desaturase (SCD1) that produces highly fluidic desaturated fatty acids, decreased the fluidity of HUVECs and increased their tolerance to DMSO. The combination of CAY10566 and antioxidant glutathione (GSH) treatment improved HUVEC viability from 57 to 69%. Membrane fluidity alteration may thus contribute to pore-induced DMSO influx into the cytoplasm and reactive oxygen species production, leading to greater cytotoxicity in HUVECs, which have low antioxidant capacity. CONCLUSIONS: Differences in freeze–thaw tolerance originate from differences in the cell membranes with respect to fluidity and antioxidant capacity. These findings provide a basis for analyzing cell biology and membrane-physics to establish appropriate long-term preservation methods aimed at promoting transplantation therapies. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13287-022-02850-y. |
format | Online Article Text |
id | pubmed-9066911 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-90669112022-05-04 Cell membrane fluidity and ROS resistance define DMSO tolerance of cryopreserved synovial MSCs and HUVECs Mizuno, Mitsuru Matsuzaki, Takahisa Ozeki, Nobutake Katano, Hisako Koga, Hideyuki Takebe, Takanori Yoshikawa, Hiroshi Y. Sekiya, Ichiro Stem Cell Res Ther Research OBJECTIVES: Synovial mesenchymal stem cells (MSCs) have high freeze–thaw tolerance, whereas human umbilical vein endothelial cells (HUVECs) have low freezing tolerance. The differences in cell type-specific freeze–thaw tolerance and the mechanisms involved are unclear. This study thus aimed to identify the biological and physical factors involved in the differences in freeze–thaw tolerance between MSCs and HUVECs. MATERIALS AND METHODS: For biological analysis, MSC and HUVEC viability after freeze-thawing and alteration of gene expression in response to dimethyl sulfoxide (DMSO, a cryoprotectant) were quantitatively evaluated. For physical analysis, the cell membrane fluidity of MSCs and HUVECs before and after DMSO addition was assessed using a histogram for generalized polarization frequency. RESULTS: HUVECs showed lower live cell rates and higher gene expression alteration related to extracellular vesicles in response to DMSO than MSCs. Fluidity measurements revealed that the HUVEC membrane was highly fluidic and sensitive to DMSO compared to that of MSCs. Addition of CAY10566, an inhibitor of stearoyl-coA desaturase (SCD1) that produces highly fluidic desaturated fatty acids, decreased the fluidity of HUVECs and increased their tolerance to DMSO. The combination of CAY10566 and antioxidant glutathione (GSH) treatment improved HUVEC viability from 57 to 69%. Membrane fluidity alteration may thus contribute to pore-induced DMSO influx into the cytoplasm and reactive oxygen species production, leading to greater cytotoxicity in HUVECs, which have low antioxidant capacity. CONCLUSIONS: Differences in freeze–thaw tolerance originate from differences in the cell membranes with respect to fluidity and antioxidant capacity. These findings provide a basis for analyzing cell biology and membrane-physics to establish appropriate long-term preservation methods aimed at promoting transplantation therapies. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13287-022-02850-y. BioMed Central 2022-05-03 /pmc/articles/PMC9066911/ /pubmed/35505370 http://dx.doi.org/10.1186/s13287-022-02850-y Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Mizuno, Mitsuru Matsuzaki, Takahisa Ozeki, Nobutake Katano, Hisako Koga, Hideyuki Takebe, Takanori Yoshikawa, Hiroshi Y. Sekiya, Ichiro Cell membrane fluidity and ROS resistance define DMSO tolerance of cryopreserved synovial MSCs and HUVECs |
title | Cell membrane fluidity and ROS resistance define DMSO tolerance of cryopreserved synovial MSCs and HUVECs |
title_full | Cell membrane fluidity and ROS resistance define DMSO tolerance of cryopreserved synovial MSCs and HUVECs |
title_fullStr | Cell membrane fluidity and ROS resistance define DMSO tolerance of cryopreserved synovial MSCs and HUVECs |
title_full_unstemmed | Cell membrane fluidity and ROS resistance define DMSO tolerance of cryopreserved synovial MSCs and HUVECs |
title_short | Cell membrane fluidity and ROS resistance define DMSO tolerance of cryopreserved synovial MSCs and HUVECs |
title_sort | cell membrane fluidity and ros resistance define dmso tolerance of cryopreserved synovial mscs and huvecs |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9066911/ https://www.ncbi.nlm.nih.gov/pubmed/35505370 http://dx.doi.org/10.1186/s13287-022-02850-y |
work_keys_str_mv | AT mizunomitsuru cellmembranefluidityandrosresistancedefinedmsotoleranceofcryopreservedsynovialmscsandhuvecs AT matsuzakitakahisa cellmembranefluidityandrosresistancedefinedmsotoleranceofcryopreservedsynovialmscsandhuvecs AT ozekinobutake cellmembranefluidityandrosresistancedefinedmsotoleranceofcryopreservedsynovialmscsandhuvecs AT katanohisako cellmembranefluidityandrosresistancedefinedmsotoleranceofcryopreservedsynovialmscsandhuvecs AT kogahideyuki cellmembranefluidityandrosresistancedefinedmsotoleranceofcryopreservedsynovialmscsandhuvecs AT takebetakanori cellmembranefluidityandrosresistancedefinedmsotoleranceofcryopreservedsynovialmscsandhuvecs AT yoshikawahiroshiy cellmembranefluidityandrosresistancedefinedmsotoleranceofcryopreservedsynovialmscsandhuvecs AT sekiyaichiro cellmembranefluidityandrosresistancedefinedmsotoleranceofcryopreservedsynovialmscsandhuvecs |